Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gerlach

Showing results (301-310 of 352) with videos related to

Pageof 36
Sort By:
Neurobiology of Aging|December 13, 2005
The aging brain: accumulation of DNA damage or neuron loss?Bart P F Rutten, Christoph Schmitz, Oliver H H Gerlach, et al.
The Journal of Biological Chemistry|April 25, 1990
A polypeptide factor produced by fibrosarcoma cells that induces endothelial tissue factor and enhances the procoagulant response to tumor necrosis factor/cachectinM Clauss, J C Murray, M Vianna, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 1985
Cefpiramide: comparative in-vitro activity and beta-lactamase stabilityA L Barry, R N Jones, C Thornsberry, et al.
Diagnostic Microbiology and Infectious Disease|August 1, 1992
Cefdinir (FK482), an orally administered cephalosporin in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelinesE H Gerlach, R N Jones, S D Allen, et al.
Journal of Clinical Microbiology|June 1, 1995
Multicenter clinical laboratory evaluation of a beta-lactamase disk assay employing a novel chromogenic cephalosporin, S1G V Doern, R N Jones, E H Gerlach, et al.
Diagnostic Microbiology and Infectious Disease|September 1, 1991
Development of Neisseria gonorrhoeae in vitro susceptibility test methods for cefixime including quality control guidelinesR N Jones, E H Gerlach, F P Koontz, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 1, 1991
Antimicrobial activity of RU29246 (HR916 metabolite) compared with four other oral beta-lactams tested against more than 5000 clinical isolatesP R Murray, S D Allen, M E Erwin, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1991
In vitro comparison of GR69153, a novel catechol-substituted cephalosporin, with ceftazidime and ceftriaxone against 5,203 recent clinical isolatesJ A Washington, R N Jones, S D Allen, et al.
The Journal of Experimental Medicine|December 1, 1990
Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migrationM Clauss, M Gerlach, H Gerlach, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 1, 1993
Interpretive criteria and quality control parameters for determining bacterial susceptibility to fosfomycin tromethamineA L Barry, M A Pfaller, P C Fuchs, et al.
Pageof 36

Showing results (301-310 of 352) with videos related to

Sort By:
Pageof 36
Neurobiology of Aging|December 13, 2005
The aging brain: accumulation of DNA damage or neuron loss?Bart P F Rutten, Christoph Schmitz, Oliver H H Gerlach, et al.
The Journal of Biological Chemistry|April 25, 1990
A polypeptide factor produced by fibrosarcoma cells that induces endothelial tissue factor and enhances the procoagulant response to tumor necrosis factor/cachectinM Clauss, J C Murray, M Vianna, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 1985
Cefpiramide: comparative in-vitro activity and beta-lactamase stabilityA L Barry, R N Jones, C Thornsberry, et al.
Diagnostic Microbiology and Infectious Disease|August 1, 1992
Cefdinir (FK482), an orally administered cephalosporin in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelinesE H Gerlach, R N Jones, S D Allen, et al.
Journal of Clinical Microbiology|June 1, 1995
Multicenter clinical laboratory evaluation of a beta-lactamase disk assay employing a novel chromogenic cephalosporin, S1G V Doern, R N Jones, E H Gerlach, et al.
Diagnostic Microbiology and Infectious Disease|September 1, 1991
Development of Neisseria gonorrhoeae in vitro susceptibility test methods for cefixime including quality control guidelinesR N Jones, E H Gerlach, F P Koontz, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 1, 1991
Antimicrobial activity of RU29246 (HR916 metabolite) compared with four other oral beta-lactams tested against more than 5000 clinical isolatesP R Murray, S D Allen, M E Erwin, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1991
In vitro comparison of GR69153, a novel catechol-substituted cephalosporin, with ceftazidime and ceftriaxone against 5,203 recent clinical isolatesJ A Washington, R N Jones, S D Allen, et al.
The Journal of Experimental Medicine|December 1, 1990
Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migrationM Clauss, M Gerlach, H Gerlach, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 1, 1993
Interpretive criteria and quality control parameters for determining bacterial susceptibility to fosfomycin tromethamineA L Barry, M A Pfaller, P C Fuchs, et al.
Pageof 36